STERLING PHARMA USA LLC
Overview
STERLING PHARMA USA LLC is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering SODIUM NITROPRUSSIDE USP.
API / Drug Master Files
STERLING PHARMA USA LLC holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- SODIUM NITROPRUSSIDE USPActive2014-05-07
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to STERLING PHARMA USA LLC in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.